ENTRY       D11355                      Drug
NAME        Elezanumab (USAN/INN)
FORMULA     C6348H9820N1684O2016S46
EXACT_MASS  143370.4816
MOL_WEIGHT  143458.9576
SEQUENCE    (Heavy chain)
            EVQLVQSGAE VKKPGASVKV SCKASGYTFT SHGISWVRQA PGQGLDWMGW ISPYSGNTNY
            AQKLQGRVTM TTDTSTSTAY MELSSLRSED TAVYYCARVG SGPYYYMDVW GQGTLVTVSS
            ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPEAAGG
            PSVFLFPPKP KDQLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN
            STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSREE
            MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
            QQGNVFSCSV LHEALHNHYT QKSLSLSPGK
            (Light chain)
            QSALTQPRSV SGSPGQSVTI SCTGTSSSVG DSIYVSWYQQ HPGKAPKLML YDVTKRPSGV
            PDRFSGSKSG NTASLTISGL QAEDEADYYC YSYAGTDTLF GGGTKVTVLG QPKAAPSVTL
            FPPSSEELQA NKATLVCLIS DFYPGAVTVA WKADSSPVKA GVETTTPSKQ SNNKYAASSY
            LSLTPEQWKS HRSYSCQVTH EGSTVEKTVA PTECS
            (Disulfide bridge: H22-H96, H147-H203, H223-L214, H229-H'229, H232-H'232, H264-H324, H370-H428, H'22-H'96, H'147-H'203, H'223-L'214, H'264-H'324, H'370-H'428, L22-L90, L137-L196, L'22-L'90,  L'137-L'196)
  TYPE      Peptide
EFFICACY    Neuroprotectant, Anti-repulsive guidance molecule RGMa antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of spinal cord injury and multiple sclerosis
TARGET      RGMA [HSA:56963] [KO:K23096]
  PATHWAY   hsa04350(56963)  TGF-beta signaling pathway
            hsa04360(56963)  Axon guidance
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Organismal systems
               Nervous system
                RGMA
                 D11355  Elezanumab (USAN/INN)
DBLINKS     CAS: 1791416-49-3
            PubChem: 384585333
///
